BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 26255568)

  • 1. Metabolic syndrome, abdominal obesity and hyperuricemia in schizophrenia: Results from the FACE-SZ cohort.
    Godin O; Leboyer M; Gaman A; Aouizerate B; Berna F; Brunel L; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Llorca PM; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Urbach M; Vidalhet P; Girerd N; Fond G;
    Schizophr Res; 2015 Oct; 168(1-2):388-94. PubMed ID: 26255568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of metabolic syndrome among inpatients with schizophrenia.
    Boke O; Aker S; Sarisoy G; Saricicek EB; Sahin AR
    Int J Psychiatry Med; 2008; 38(1):103-12. PubMed ID: 18624022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjects.
    Meshkani R; Zargari M; Larijani B
    Acta Diabetol; 2011 Mar; 48(1):79-88. PubMed ID: 21046418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this?
    Azimi-Nezhad M; Herbeth B; Siest G; Dadé S; Ndiaye NC; Esmaily H; Hosseini SJ; Ghayour-Mobarhan M; Visvikis-Siest S
    Metab Syndr Relat Disord; 2012 Jun; 10(3):181-8. PubMed ID: 22283632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IDEA study (International Day for the Evaluation of Abdominal Obesity): primary care study of the prevalence of abdominal obesity and associated risk factors in Colombia].
    Ruiz ÁJ; Aschner PJ; Puerta MF; Cristancho RA
    Biomedica; 2012; 32(4):610-6. PubMed ID: 23715236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperuricemia and metabolic syndrome in children with overweight and obesity.
    Civantos Modino S; Guijarro de Armas MG; Monereo Mejías S; Montaño Martínez JM; Iglesias Bolaños P; Merino Viveros M; Ladero Quesada JM
    Endocrinol Nutr; 2012 Nov; 59(9):533-8. PubMed ID: 23089370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.
    Gupta R; Sharma KK; Gupta A; Agrawal A; Mohan I; Gupta VP; Khedar RS; Guptha S
    J Assoc Physicians India; 2012 Mar; 60():11-6. PubMed ID: 22799108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uric acid level as a risk marker for metabolic syndrome: a Chinese cohort study.
    Yang T; Chu CH; Bai CH; You SL; Chou YC; Chou WY; Chien KL; Hwang LC; Su TC; Tseng CH; Sun CA
    Atherosclerosis; 2012 Feb; 220(2):525-31. PubMed ID: 22154195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The METEOR study: frequency of metabolic disorders in patients with schizophrenia. Focus on first and second generation and level of risk of antipsychotic drugs.
    Falissard B; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; De Hert M
    Int Clin Psychopharmacol; 2011 Nov; 26(6):291-302. PubMed ID: 21876442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
    Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
    Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence and interrelationships between cardio-metabolic risk factors in abdominally obese individuals.
    Pettman TL; Buckley JD; Coates AM; Misan GM; Petkov J; Howe PR
    Metab Syndr Relat Disord; 2009 Feb; 7(1):31-6. PubMed ID: 19025446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum uric acid is associated with metabolic risk factors for cardiovascular disease in the Uygur population.
    Li NF; Wang HM; Yang J; Zhou L; Yao XG; Hong J
    Appl Physiol Nutr Metab; 2009 Dec; 34(6):1032-9. PubMed ID: 20029511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome and its association with serum uric acid levels in Bangkok Thailand.
    Jaipakdee J; Jiamjarasrangsri W; Lohsoonthorn V; Lertmaharit S
    Southeast Asian J Trop Med Public Health; 2013 May; 44(3):512-22. PubMed ID: 24050084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data set.
    Fond G; Godin O; Brunel L; Aouizerate B; Berna F; Bulzacka E; Capdevielle D; Chereau I; Dorey JM; Dubertret C; Dubreucq J; Faget C; Gabayet F; Le Strat Y; Micoulaud-Franchi JA; Misdrahi D; Rey R; Richieri R; Passerieux C; Schandrin A; Schürhoff F; Tronche AM; Urbach M; Vidalhet P; Llorca PM; Leboyer M;
    J Affect Disord; 2016 Feb; 191():209-15. PubMed ID: 26674214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seasonal pattern in bipolar disorders and cardio-vascular risk factors: A study from the FACE-BD cohort.
    Geoffroy PA; Godin O; Mahee D; Henry C; Aubin V; Azorin JM; Bougerol T; Courtet P; Gard S; Kahn JP; Passerieux C; Leboyer M; Bellivier F; Etain B;
    Chronobiol Int; 2017; 34(7):845-854. PubMed ID: 28537802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positively increased visceral adiposity index in hyperuricemia free of metabolic syndrome.
    Gu D; Ding Y; Zhao Y; Miao S; Qu Q
    Lipids Health Dis; 2018 May; 17(1):101. PubMed ID: 29734946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low prevalence of obesity and metabolic syndrome in never-treated chronic schizophrenia.
    Padmavati R; McCreadie RG; Tirupati S
    Schizophr Res; 2010 Aug; 121(1-3):199-202. PubMed ID: 20538429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic risk factors in first-episode schizophrenia: baseline prevalence and course analysed from the European First-Episode Schizophrenia Trial.
    Fleischhacker WW; Siu CO; Bodén R; Pappadopulos E; Karayal ON; Kahn RS;
    Int J Neuropsychopharmacol; 2013 Jun; 16(5):987-95. PubMed ID: 23253821
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperuricemia and metabolic syndrome: lessons from a large cohort from Israel.
    Cohen E; Krause I; Fraser A; Goldberg E; Garty M
    Isr Med Assoc J; 2012 Nov; 14(11):676-80. PubMed ID: 23240372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.